HOME > MARKETS > COMPANY NEWS
  COMPANY NEWS
COMPANY
Lupin’s arm launches VITALYFE
Nov-13-2025

Lupin’s wholly owned subsidiary -- Lupin Digital Health has launched VITALYFE, an AI-powered cardiometabolic wellness platform designed to help India’s working professionals reclaim their heart health. Built on the foundation of LYFE - India’s first CDSCO-approved Class C software medical device (SaMD) for critical cardiac conditions - VITALYFE extends hospital-grade cardiac expertise to preventive wellness for its users. 

Developed with industry-leading cardiometabolic expertise, VITALYFE uses artificial intelligence, behavioral science, and computer-vision technology to identify early risks and provide personalized, non-medical interventions that address the root causes of heart aging. Available exclusively through insurers, brokers, and employers, the platform enables organizations to integrate cardiometabolic wellness into their health benefits - improving productivity, engagement, and overall well-being while helping insurers reduce lifestyle-related claims. 

VITALYFE is a wellness platform designed for general health and lifestyle management. It is not intended to diagnose, treat, cure, or prevent any disease. The platform fully complies with India’s Digital Personal Data Protection (DPDP) Act, is ISO 27001-certified, and ensures that all user data is securely stored within India.

Lupin is an innovation led transnational pharmaceutical company producing, developing and marketing a wide range of branded and generic formulations, biotechnology products and active pharmaceutical ingredients (APIs) globally.

  RELATED NEWS >>